References
- Mishima Y. Thromboangiitis obliterans (Buerger’s disease). Int J Cardiol 1996;54(Suppl.):S185–S187
- Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–7
- Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434–8
- Jia L, Takahashi M, Yoshioka T, et al. Therapeutic potential of endothelial progenitor cells for cardiovascular diseases. Curr Vasc Pharmacol 2006;4:59–65
- Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952–8
- Gehling UM, Ergun S, Schumacher U, et al. In vivo differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95:3106–12
- Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001;103:897–903
- Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with critical limb ischemia using autologous bone marrow cell transplantation: a randomized, multicenter, controlled trial. Lancet 2002;360:427–35
- Matsui K, Murakami Y, Yoshioka T, et al. Therapeutic angiogenesis by transplantation of autologous bone marrow and peripheral blood mononuclear cells in patients with peripheral arterial disease. Int J Angiol 2003;12:155–61
- Saigawa T, Kato K, Ozawa T, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 2004;68: 1189–93
- Eizawa T, Murakami Y, Matsui K, et al. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr Med Res Opin 2003;19:627–33
- Zimmerman NB, Zimmerman SI, McClinton MA, et al. Long-term recovery following surgical treatment for ulnar artery occlusion. J Hand Surg 1994;19:17–21
- Mehta T, Venkata Subramaniam A, Chetter I, et al. Assessing the validity and responsiveness of disease-specific quality of life instruments in intermittent claudication. Eur J Vasc Endovasc Surg 2006;31:46–52
- Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 1987;329:630–2
- Nizankowski R, Petriczek T, Skotnicki A, et al. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol 2005;63:351–60
- Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 2001;103:897–903
- Shyu KG, Manor O, Magner M, et al. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998;98:2081–7
- Takakura N, Watanabe T, Suenobu S. A role for hematopoietic stem cells in promoting angiogenesis. Cell 2000;102:199–209